Management and Treatment of Pediatric Asthma: Update
Much of what we know about the pathogenesis and treatment of asthma has been learned from adult studies. Recently, a dramatic shift toward the pediatric age group has occurred in both of these areas. Such studies in children have overall supported similarities with the adult population with regard to pathogenesis (airway inflammation) and treatment (anti-inflammatory controller medications). However, the onset of asthma symptoms in less than 5 years is 80% of the time, yet controller medications approved for children under 4 years of age have generally not been available. This treatment gap was recently filled by the FDA approval of two important asthma controller medications. This review will focus on the use of leukotriene receptor antagonists and inhaled corticosteroids, which were recently approved for use in asthmatic children under 4 years of age.
Document Type: Research Article
Publication date: 01 March 2001
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service. - Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Commercial level: Permission to use content
- www.JFoodAllergy.com
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content